CRYSTAL-STRUCTURE OF A CHIMERIC FAB' FRAGMENT OF AN ANTIBODY-BINDING TUMOR-CELLS

被引:50
作者
BRADY, RL [1 ]
EDWARDS, DJ [1 ]
HUBBARD, RE [1 ]
JIANG, JS [1 ]
LANGE, G [1 ]
ROBERTS, SM [1 ]
TODD, RJ [1 ]
ADAIR, JR [1 ]
EMTAGE, JS [1 ]
KING, DJ [1 ]
LOW, DC [1 ]
机构
[1] CELLTECH LTD,DIV CELLTECH RES,SLOUGH SL1 4EN,ENGLAND
关键词
ANTIBODY; FAB'FRAGMENT; PROTEIN CRYSTALLOGRAPHY; MOLECULAR REPLACEMENT; ANTIBODY HUMANIZATION;
D O I
10.1016/0022-2836(92)90695-G
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of a chimeric Fab′ fragment of a monoclonal antibody is presented. The Fab′ comprises the murine light chain and heavy chain variable domains of the carcinoma-binding antibody B72.3 fused to the constant domain of human κ, and the first constant domain and hinge domain of human γ4, respectively. A model for the Fab′ has been determined by molecular replacement and refined to a resolution of 3·1 Å with an R-factor of 17·6%. The additional residues that distinguish a Fab′ from a Fab fragment are seen to be disordered in the crystals. The H3 hypervariable loop is short and adopts a sharp hairpin turn in a conformation that results from an interaction between the lysine side-chain of H93 and the main-chain carbonyl group of H96. The remaining hypervariable loops display conformations similar to those predicted from the canonical structures approach, although loop H2 is apparently displaced by a salt-bridge formed between H55 Asp and the neighbouring H73 Lys. These and other features of the structure likely to be important in grafting the hypervariable loops to an otherwise human framework are discussed. © 1992.
引用
收藏
页码:253 / 264
页数:12
相关论文
共 43 条
[21]  
KJELDSEN T, 1988, CANCER RES, V48, P2214
[22]  
Maeda H, 1991, Hum Antibodies Hybridomas, V2, P124
[23]   CRYSTALLOGRAPHIC REFINEMENT AND ATOMIC MODELS OF THE INTACT IMMUNOGLOBULIN MOLECULE KOL AND ITS ANTIGEN-BINDING FRAGMENT AT 3.0-A AND 1.9-A RESOLUTION [J].
MARQUART, M ;
DEISENHOFER, J ;
HUBER, R ;
PALM, W .
JOURNAL OF MOLECULAR BIOLOGY, 1980, 141 (04) :369-391
[24]  
MEZES P, 1990, Patent No. 365997
[25]   CLONING IMMUNOGLOBULIN VARIABLE DOMAINS FOR EXPRESSION BY THE POLYMERASE CHAIN-REACTION [J].
ORLANDI, R ;
GUSSOW, DH ;
JONES, PT ;
WINTER, G .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (10) :3833-3837
[26]   A POSSIBLE PROCEDURE FOR REDUCING THE IMMUNOGENICITY OF ANTIBODY VARIABLE DOMAINS WHILE PRESERVING THEIR LIGAND-BINDING PROPERTIES [J].
PADLAN, EA .
MOLECULAR IMMUNOLOGY, 1991, 28 (4-5) :489-498
[27]   A HUMANIZED ANTIBODY THAT BINDS TO THE INTERLEUKIN-2 RECEPTOR [J].
QUEEN, C ;
SCHNEIDER, WP ;
SELICK, HE ;
PAYNE, PW ;
LANDOLFI, NF ;
DUNCAN, JF ;
AVDALOVIC, NM ;
LEVITT, M ;
JUNGHANS, RP ;
WALDMANN, TA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (24) :10029-10033
[28]  
Ramachandran G N, 1968, Adv Protein Chem, V23, P283, DOI 10.1016/S0065-3233(08)60402-7
[29]   RESHAPING HUMAN-ANTIBODIES FOR THERAPY [J].
RIECHMANN, L ;
CLARK, M ;
WALDMANN, H ;
WINTER, G .
NATURE, 1988, 332 (6162) :323-327